How AstraZeneca Is Playing Its Cancer Cards To Become An $80 ... Japan, the U.K. and the U.S. each year, Dave Fredrickson, executive vice president of AstraZeneca's oncology business unit, ...

In collaboration with AstraZeneca and Genpact, the company’s business process outsourcing partner, Trintech implemented its Certification solution to manage reconciliations of AstraZeneca’s ...

AstraZeneca works with IBM to unlock the power of cognitive digitization for business value ... Yet, it’s worth noting what’s on the business card for Mark Clare (pictured, left).

AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 billion to increase its stock of heart and kidney drugs.